Pfizer Agrees to Settle 10,000 Zantac Lawsuits Over Alleged Cancer Risks, Bloomberg Reports

-- Pfizer has agreed to settle over 10,000 cases against its heartburn drug Zantac for allegedly hiding cancer-associated risks, Bloomberg reports, citing people familiar with the deal.

-- The agreements cover cases in state courts across the U.S., but don't completely resolve the company's exposure to Zantac claims, Bloomberg reports.

-- "Pfizer has explored and will continue to explore opportunistic settlements of certain cases if appropriate, and has settled certain cases," Pfizer said in a statement, according to Bloomberg. "The company has not sold a Zantac product in more than 15 years and did so only for a limited period of time."

-- Zantac has been owned by different drugmakers in its more than 30-year run as one of the most popular antacids in the U.S., Bloomberg reports.

Full article at https://www.bloomberg.com/news/articles/2024-05-08/pfizer-agrees-to-settle-more-than-10-000-zantac-cancer-lawsuits

Write to Sabela Ojea at sabela.ojea@wsj.com

(END) Dow Jones Newswires

May 08, 2024 13:47 ET (17:47 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.